MY151414A - Stability of proteins in aqueous suspension - Google Patents

Stability of proteins in aqueous suspension

Info

Publication number
MY151414A
MY151414A MYPI20033829A MY151414A MY 151414 A MY151414 A MY 151414A MY PI20033829 A MYPI20033829 A MY PI20033829A MY 151414 A MY151414 A MY 151414A
Authority
MY
Malaysia
Prior art keywords
antigen
hbsag
solution
stability
proteins
Prior art date
Application number
Other languages
English (en)
Inventor
Contorni Maria
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Publication of MY151414A publication Critical patent/MY151414A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MYPI20033829 2002-10-08 2003-10-08 Stability of proteins in aqueous suspension MY151414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0223355.9A GB0223355D0 (en) 2002-10-08 2002-10-08 Vaccine

Publications (1)

Publication Number Publication Date
MY151414A true MY151414A (en) 2014-05-30

Family

ID=9945519

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20033829 MY151414A (en) 2002-10-08 2003-10-08 Stability of proteins in aqueous suspension

Country Status (5)

Country Link
KR (1) KR20030083665A (zh)
CN (2) CN102716477B (zh)
AR (1) AR041557A1 (zh)
GB (1) GB0223355D0 (zh)
MY (1) MY151414A (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20100365A1 (es) 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2118963T3 (es) * 1992-05-23 1998-10-01 Smithkline Beecham Biolog Vacunas combinadas, que contienen antigeno de superficie de la hepatitis b y otros antigenos.
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
AR041557A1 (es) 2005-05-18
KR20030083665A (ko) 2003-10-30
CN102716477B (zh) 2015-07-29
CN1550236B (zh) 2012-06-20
GB0223355D0 (en) 2002-11-13
CN1550236A (zh) 2004-12-01
CN102716477A (zh) 2012-10-10

Similar Documents

Publication Publication Date Title
NZ506604A (en) HiB/DTPa vaccine composition and method of preparation
PL345018A1 (en) Particles of hcv envelope proteins: use for vaccination
PL1951299T3 (pl) Szczepionki przeciw grypie zawierające kombinacje adiuwantów cząsteczkowych i czynników wzmacniających immunogenność
WO2005107381A3 (en) Use of flagellin as an adjuvant for vaccine
HK1052629A1 (en) Proteosome influenza vaccine
GB0118249D0 (en) Histidine vaccines
IL164812A0 (en) Packaged virus-like particles for use as adjuvants: method of preparation and use
DE60039198D1 (de) Adjuvanszusammensetzungen zur Erhöhung der Immunantwort bezüglich Polynukleotid-basierenden Impfstoffen
PL1635863T3 (pl) Kompozycje do wywoływania, wzmacniania i utrzymywania odpowiedzi immunologicznych na epitopy ograniczone do MHC klasy I do celów profilaktycznych i leczniczych
WO2007052155A3 (en) Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
EA200501070A1 (ru) Поливалентная вакцинная композиция
JP2012506421A5 (zh)
NZ592977A (en) IgE CH3 PEPTIDE VACCINE
RU2006136212A (ru) КОМБИНИРОВАННЫЕ ВАКЦИНЫ С НИЗКОЙ ДОЗОЙ КОНЬЮГАТА Hib
SG158154A1 (en) Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
MXPA02012039A (es) Composiciones en polvo.
SG160328A1 (en) Adjuvant composition comprising aluminium phosphate and 3d-mpl
WO1999050303A3 (en) Immune response modulator alpha-2 macroglobulin complex
RU2011135761A (ru) Комбинированная вакцина с цельноклеточным коклюшем
RU2007112117A (ru) Вакцинная композиция против вируса гепатита с
MY143688A (en) Manufacturing method of combined vaccine
MY151414A (en) Stability of proteins in aqueous suspension
MX2008001527A (es) Reduccion de interferencia entre adyuvantes que contienen aceite y antigenos que contienen agentes tensioactivos.
WO2005021726A3 (en) Immunogenic hiv compositions and related methods
WO2002038611A3 (en) Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins